7h
Zacks Investment Research on MSNApyx Medical (APYX) Reports Q4 Loss, Tops Revenue EstimatesApyx Medical (APYX) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.19 per share a year ago. These figures are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results